**2024 EHA | Breaking Through Multiple Myeloma Treatment Bottlenecks: Significant Advances of Equecabtagene Autoleucel in High-Risk NDMM Patients**
**2024 EHA | Breaking Through Multiple Myeloma Treatment Bottlenecks: Significant Advances of Equecabtagene Autoleucel in High-Risk NDMM Patients**
![Multiple Myeloma](https://www.medtourcn.com/wp-content/uploads/2024/07/微信截图_20240712114012.jpg)
Multiple Myeloma